Devanarayan V, Ye Y, Zhu L, Tian L, et al. Predicted natural progression as an Alzheimer's prognostic covariate improves the precision of lecanemab efficacy assessments and clinical trial efficiency. Alzheimers Dement 2025;21:e70045.
PMID: 40042496